Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 210-438-6 | CAS number: 615-60-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 2004
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- According to OECD 425 guideline; under GLP conditions. The substance cited in section 1.1 (identification) and the structural analogue used in this study differ only in their regiochemistry. Both compounds possess similar chemical functional groups (aromatic carbon and aromatic carbon attached to chlorine) and are therefore expected to possess similar chemical reactivities. This study has been performed using 3-chloro-o-xylene as the test material but it is expected that the test substance will produce a similar result.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 004
- Report date:
- 2004
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 425 (Acute Oral Toxicity: Up-and-Down Procedure)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- up-and-down procedure
- Limit test:
- yes
Test material
- Reference substance name:
- 1-chloro-2,3-dimethylbenzene
- Cas Number:
- 608-23-1
- Molecular formula:
- C8H9Cl
- IUPAC Name:
- 1-chloro-2,3-dimethylbenzene
- Details on test material:
- - Name of test material (as cited in study report): 3-chloro-o-xylene
- Molecular formula (if other than submission substance): C8H9Cl
- Molecular weight (if other than submission substance): 140.61
- Physical state: Liquid
- Storage condition of test material: Room temperature, dry place
- Other: Stable under recommended conditions of storage and handling.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Outbred albino rat (Rattus norvegicus)
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source:Harlan, Indianapolis, IN
- Age at study initiation: at least 49 days old
- Weight at study initiation: 201.5 - 247.5 grams
- Housing: Housed individually in polycarbonate cages.
- Diet (e.g. ad libitum): TEK 7012 Rodent Diet, Harlan Teklad, Madison WI, ad libitum
- Water (e.g. ad libitum): Tap water ad libitum
- Acclimation period: Minimum of 5 days under the same conditions as the main test.
ENVIRONMENTAL CONDITIONS
- Temperature (°F): 68 +/- 5
- Humidity (%): 30 - 70%
- Air changes (per hr): 10 - 15
- Photoperiod: 12 hours light / 12 hours dark
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Test material is a liquid and did not require further preparation prior to dosing. The volume administered did not exceed 1ml/100g body weight.
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- - Clinical observations were observed at least twice daily on the day of dosing (frequency of observation was determined according to the response of the test animal to the treatment). Animals were observed daily for 14 days for clinical signs. Cageside observations include: changes in the the skin and fur, eyes and mucous membranes and also respiratory, circulatory, autonomic and central nervous system and somatomotor activity and behaviour pattern. Particular attention was directed to observations of tremors, convulsions, salivation, diarrhoea, lethargy, sleep and coma.
- Animals found dead were necropsied as soon as possible (no later than 12 hours). Gross necropsies were performed on all animals whether found dead in extremis or sacrified (by CO2 inhalation) at the end of the study and gross pathological changes were recorded.
- Animals were weighed on Day 0 prior to treatment, day7, day 14 and at death.
Results and discussion
Effect levels
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- > 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- 3 of the 5 animals survived the duration of the study. 2 of the 5 animals died during the observation period (on day 4 and 12).
- Clinical signs:
- other: In 4 of the 5 animals, no signs of toxicity were observed. In one animal piloerection was observed 4 hours after treatment.
- Gross pathology:
- No unusual findings were observed during the necropsy of all dosed animals.
Any other information on results incl. tables
Input of the results into the statistical program (AOT425StatPgm) developed by the US Environmental Protection Agency, suggests that the test material has an LD50 of > 2000 mg/kg.
Analogue approach justification:
The test substance 4-chloro-o-xylene and the structural analogue, 3-chloro-o-xylene differ only in their regiochemistry i.e. in the position of the chlorine atom on the ring. These compounds possess similar chemical functional groups (aromatic carbon and aromatic carbon attached to chlorine) and are therefore expected to possess similar chemical reactivities. This study has been performed using 3-chloro-o-xylene as the test material but it is expected that the 4-chloro-o-xylene will produce a similar result.
Applicant's summary and conclusion
- Interpretation of results:
- relatively harmless
- Remarks:
- Migrated information Criteria used for interpretation of results: expert judgment
- Conclusions:
- Under the conditions of this study, the test material has been determined as having an acute oral LD50 of >2000 mg/kg.
- Executive summary:
The study was performed to assess the acute oral toxicity of the test material in the Outbred Albino rats. The study was performed to GLP and the method was designed to meet the requirements of OECD Guidelines for Testing of Chemicals No. 425 “Acute Oral Toxicity - Up and Down procedure”.
The test material was administered orally, after overnight fasting, once only by intragastric intubation. The administered volume did not exceed 1ml/100g body weight. Following a preliminary test in which a single female was dosed with the test material at 2000 mg/kg body weight, there was no mortality. Accordingly, an additional four females were given the same dose of 2000 mg/kg bodyweight. Clinical signs and bodyweight development were monitored during the study. All females were subjected to gross necropsy after an observation period of 14 days.
Two out of five females died during the study. In four out of five females, no signs of toxicity were observed during the study. One female exhibited piloerection within 4 hours of test substance administration. Females that survived the duration of the study showed expected gains in bodyweight. No abnormalities were noted at necropsy. The statistical computer program (AOT425StatPgm) estimated an acute oral median lethal dose (LD50) of the test material in the female Outbred Albino rats as greater than 2000 mg/kg bodyweight.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.